Table 3.

Tumor and liver IGF-I and IGF-II levels in athymic nude mice bearing Caki-I xenografts after treatment with the GH-RH antagonist MZ-4-71

Treatment group	Tumor		Liver
	IGF-I	IGF-II, pg/100 μg protein	IGF-I, pg/100 μg protein
Control	726  ±  126	4580  ±  628.1	135.2  ±  10.4
MZ-4-71	362.5  ±  45*	2,438.5  ±  103.5*	97.0  ±  6.6*

All values are means ± SEM. ∗, P < 0.05 versus control.